Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
Decreased NOSTRIN expression found with initiation and progression of advanced colon cancer disease stages.
»
05/31/22
Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer
c-MYC protein downregulated in miRNA-treated TNBC cells.
»
05/31/22
Multinomial network meta-analysis using response rates: relapsed/refractory multiple myeloma treatment rankings differ depending on the choice of outcome
Top three dominated by same triplets.
»
05/30/22
Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning
Olfactory receptor activities and similar terms enriched for up-regulated genes.
»
06/04/22
The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.
Mediation effect of combined lifestyle factors on GC modest.
»
01/04/22
A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer.
Maintaining healthy lifestyle may provide way to offset genetic risk.
»
12/23/21
Impact of genomic assays on treatment and outcomes in locally advanced breast cancer.
Endocrine therapy alone associated with worse OS.
»
11/07/21
LXRβ Activation Inhibits the Proliferation of Small-cell Lung Cancer Cells by Depleting Cellular Cholesterol.
Antitumoral effect of LXR agonist on SCLC cells attributed to induction of ABCA1.
»
04/08/22
Survival in adult patients with BRAFV600 mutation-positive advanced melanoma: a noninterventional ambispective study of patients with cobimetinib combined with vemurafenib during the French early access program: MELANIS study.
Combination therapy effective.
»
05/31/22
Dynamic changes in longitudinal circulating tumour DNA profile during metastatic colorectal cancer treatment.
Newly identified mutations could be potential candidates of targeted therapy.
»
11/08/21
< Prev
Next >